Paula Soteropoulos's Net Worth

$11.8 Million

Estimate Recalculated Apr 1, 2024 05:22PM EST

Who is Paula Soteropoulos?

Paula Soteropoulos has an estimated net worth of $11.8 Million. This is based on reported shares across multiple companies, which include uniQure N.V., Rallybio Corp, AKCEA THERAPEUTICS, INC., and Dianthus Therapeutics, Inc. /DE/.

SEC CIK

Paula Soteropoulos's CIK is 0001692444

Past Insider Trading and Trends

2019 was Paula Soteropoulos's most active year for acquiring shares with 11 total transactions. Paula Soteropoulos's most active month to acquire stocks was the month of December. 2019 was Paula Soteropoulos's most active year for disposing of shares, totalling 17 transactions. Paula Soteropoulos's most active month to dispose stocks was the month of November. 2019 saw Paula Soteropoulos paying a total of $14,874,114.99 for 2,420,559 shares, this is the most they've acquired in one year. In 2019 Paula Soteropoulos cashed out on 3,560,711 shares for a total of $25,567,851.31, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

uniQure N.V. (QURE) Snapshot price: $5.675

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+40.16%
6.42K
$18.99
-$43,202.25
22.42K
Jun 13 - Jun 16
Form 4
-2.34%
-384.00
$19.97
-$7,668.48
16K
Feb 27
Form 4
—
0
$13.98
-$103,320.00
16.38K
Scheduled
Jan 18
Form 4
—
0
$14.41
-$159,384.00
16.38K
Scheduled
Dec 13 - Dec 14
Form 4
—
0
$25.38
-$157,356.00
16.38K
Scheduled
Nov 29
Form 4
+124.35%
9.08K
—
—
16.38K
Jun 15
Form 4
-7.55%
-596.00
$16.87
-$10,054.52
7.3K
Feb 28
Form 4
+24.10%
1.53K
—
—
7.9K
Feb 24
Form 4
-7.34%
-504.00
$37.60
-$18,950.40
6.36K
Mar 2
Form 4
+53.10%
2.38K
—
—
6.87K
Feb 25
Form 4
+85.14%
2.06K
—
—
4.49K
Feb 27
Form 4
-46.69%
-2.12K
$60.95
-$129,331.66
2.42K
Scheduled
Feb 5
Form 4
-15.08%
-807.00
$62.19
-$50,187.33
4.54K
Jan 28
Form 4
-35.92%
-3.00K
$72.18
-$216,540.00
5.35K
Scheduled
Jan 7
Form 4
—
0
$37.94
-$130,260.00
8.35K
Scheduled
Dec 13
Form 4
-58.10%
-11.58K
$64.96
-$752,349.98
8.35K
Scheduled
Dec 6 - Dec 9
Form 4
-5.72%
-1.21K
$31.32
-$37,897.20
19.93K
Jan 28
Form 4
+18.03%
3.23K
—
—
21.14K
Jan 25
Form 4
-13.84%
-2.88K
$18.53
-$53,329.34
17.91K
Jan 29
Form 4
+29.95%
4.79K
—
—
20.79K
Jan 26
Form 4
—
0
—
—
0
Jan 27
Form 3
—
0
—
—
0
No matching records found

Rallybio Corp (RLYB) Snapshot price: $1.59

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Jan 3
Form 3
—
0
—
—
0
No matching records found

AKCEA THERAPEUTICS, INC. No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
678.15K
$11.85
-$8,486,713.73
678.15K
Sep 26
Form 4
—
0
$19.30
-$814,800.52
0
Scheduled
Apr 5 - Apr 8
Form 4
—
0
$19.31
-$471,714.89
0
Scheduled
Mar 6
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 3
—
0
—
—
0
No matching records found

Dianthus Therapeutics, Inc. /DE/ (DNTH) Snapshot price: $23.49

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 11
Form 3
—
0
—
—
0
No matching records found